Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,858 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study group.
Motomura K, Sasaki K, Sugii N, Yamaguchi S, Inoue H, Oshima A, Tanaka K, Otani Y, Shirahata M, Shibahara I, Nagane M, Tsuzuki S, Matsutani T, Tsukamoto Y, Kijima N, Asano K, Ohno M, Inoue A, Mineharu Y, Miyake K, Mitobe Y, Hanihara M, Kawanishi Y, Deguchi S, Saito M, Matsuda R, Ujifuku K, Arita H, Sato Y, Yamashita S, Yonezawa U, Yamaguchi J, Momii Y, Ogawa T, Kambe A, Ohba S, Fukai J, Saito N, Kinoshita M, Sumi K, Otani R, Uzuka T, Takebe N, Koizumi S, Saito R, Arakawa Y, Narita Y; Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG). Motomura K, et al. Among authors: sasaki k. Jpn J Clin Oncol. 2024 Oct 3;54(10):1123-1131. doi: 10.1093/jjco/hyae116. Jpn J Clin Oncol. 2024. PMID: 39223700 Free PMC article.
Protocol digest of a randomized controlled adaptive Phase II/III trial of neoadjuvant chemotherapy for Japanese patients with oesophagogastric junction adenocarcinoma: Japan Clinical Oncology Group Study JCOG2203 (NEO-JPEG).
Kita R, Yanagimoto Y, Imazeki H, Booka E, Tsushima T, Mizusawa J, Sasaki K, Fukuda H, Kurokawa Y, Takeuchi H, Kato K, Kitagawa Y, Boku N, Yoshikawa T, Terashima M; Stomach Cancer Study Group and Japan Esophageal Oncology Group of the Japan Clinical Oncology Group. Kita R, et al. Among authors: sasaki k. Jpn J Clin Oncol. 2024 Feb 7;54(2):206-211. doi: 10.1093/jjco/hyad149. Jpn J Clin Oncol. 2024. PMID: 37952093
Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021-22.
Imaoka H, Sasaki K, Machida R, Nagano H, Satoi S, Ikeda M, Kobayashi S, Yamashita T, Okusaka T, Ido A, Hatano E, Miwa H, Ueno M, Nakao K, Shimizu S, Kuramochi H, Sakamori R, Tsumura H, Okano N, Shioji K, Shirakawa H, Akutsu N, Tsuji K, Ishii H, Umemoto K, Asagi A, Ueno M; JCOG Hepatobiliary and Pancreatic Oncology Group. Imaoka H, et al. Among authors: sasaki k. Jpn J Clin Oncol. 2024 Oct 3;54(10):1071-1077. doi: 10.1093/jjco/hyae048. Jpn J Clin Oncol. 2024. PMID: 38843879
High cost of chemotherapy for gynecologic malignancies.
Takahashi N, Seki T, Sasaki K, Machida R, Ishikawa M, Yunokawa M, Matsuoka A, Kagabu M, Yamaguchi S, Hiranuma K, Ohnishi J, Sato T. Takahashi N, et al. Among authors: sasaki k. Jpn J Clin Oncol. 2024 Oct 3;54(10):1078-1083. doi: 10.1093/jjco/hyae089. Jpn J Clin Oncol. 2024. PMID: 39023439
Frequency of use and cost in Japan of first-line palliative chemotherapies for recurrent or metastatic squamous cell carcinoma of the head and neck.
Yokoyama K, Wasano K, Sasaki K, Machida R, Nakahira M, Kitamura K, Sakagami T, Takeshita N, Ohkoshi A, Suzuki M, Tateya I, Morishita Y, Sekimizu M, Nakayama M, Koyama T, Shibata H, Miyamaru S, Kiyota N, Hanai N, Homma A. Yokoyama K, et al. Among authors: sasaki k. Jpn J Clin Oncol. 2024 Oct 3;54(10):1115-1122. doi: 10.1093/jjco/hyae117. Jpn J Clin Oncol. 2024. PMID: 39206595
Protocol digest of a phase III randomized trial of gross total resection versus possible resection of fluid-attenuated inversion recovery-hyperintense lesion on MRI for newly diagnosed supratentorial glioblastoma: JCOG2209 (FLAMINGO).
Sekino Y, Sonoda Y, Shibahara I, Mizusawa J, Sasaki K, Sekita T, Ichikawa M, Igaki H, Kinoshita M, Kumabe T, Shibahara J, Ichimura K, Arakawa Y, Fukuda H; Brain Tumor Study Group (BTSG) of the Japan Clinical Oncology Group (JCOG); Narita Y. Sekino Y, et al. Among authors: sasaki k. Jpn J Clin Oncol. 2024 Sep 17:hyae130. doi: 10.1093/jjco/hyae130. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39292165
[No title available]
[No authors listed] [No authors listed] PMID: 39295330
Multicenter randomized phase III study of high-dose therapy with autologous stem cell transplantation versus observation for patients with newly diagnosed peripheral T-cell lymphoma who achieved complete metabolic response after induction therapy (JCOG2210, TRANSFER study).
Kita R, Shimada K, Machida R, Sekita T, Sasaki K, Ishitsuka K, Fukuda H, Maruyama D, Munakata W, Nagai H; Japan Clinical Oncology Group Lymphoma Study Group. Kita R, et al. Among authors: sasaki k. Jpn J Clin Oncol. 2024 Oct 19:hyae144. doi: 10.1093/jjco/hyae144. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39426803
6,858 results